THE FUTURE OF HEALTHCARE IS TARGETED, AND IT IS PRECISE

8-9 May 2024. Sheikh Rashid Hall, Dubai World Trade Centre

7,000
Visitors

100
Exhibitors

2
World-class conferences

100
Global knowledge leaders

20+
Workshops and side-events

Why Visit PMES 2024?

EXHIBITION

Meet 100+ exhibitors

Discover innovations driving the future of precision medicine from molecular diagnostics, biomarker discovery, and other cutting-edge techniques for disease detection and monitoring that guide personalised patient diagnosis & treatment.

Precision Nexus stage

Workshops and side events

Hear from the pioneers revolutionising the future of precision medicine, learn about new technologies and solutions, and adapt to the changing times through exclusive workshops side events and discussions.

scientific conference

CME accredited

Learn from 100+ thought leaders and industry experts who will dive deep into the new frontiers of precision medicine technologies, trends, digitisation and more.

View conference agenda

Precision Genquest

Empowering next generation of scientists

A competition dedicated to PhD and Masters degree students, inviting them to present their research at PrecisionMed Exhibition & Summit. Students are encouraged to present their findings in a visually compelling manner to a highly targeted audience of scientists, researchers, and visionaries.

Submit your abstract

EMERGE 2050

Over $1 billion in funds available to healthtech innovators

EMERGE 2050 Forum is co-located with PMES and is dedicated to innovations in healthtech, medtech and biotech, all with the purpose of increasing operational efficiency and saving costs across the healthcare ecosystem.

Exhibit your startup

NETWORKING

Setup meetings in advance with the networking app

Make connections with decision makers, influential professionals and practitioners in precision medicine and genome based healthcare. Discuss new ways to generate business, source and launch products, establish a strong presence in the MENA region.

Register today

network with 100+ exhibitors

VISITOR PASS

free entry

Includes access to:
  • Exhibition zone where 100+ leading brands will be showcasing the latest developments

  • Precision Nexus Stage – Workshops and side events by leading brands in precision medicine.

  • EMERGE 2050 Summit & The Nest Exhibition zone

  • Precision GenQuest – Empowering the next generation of scientists!

  • Illumina Cancer Genomics Summit – Presented by an international lineup of experts addressing the challenges and unveiling the opportunities in precision oncology and revolutionary cancer management techniques

DELEGATE PASS

$499

Early bird prices valid until 16 April.

$399 for government & Ph.D. research students.

For govt., use code: GOVPMES24
For students, use code: STUPMES24

Includes access to:
  • Everything included in the visitor registration plus;

  • Full access to CME accredited Scientific Conference on the PMES Main Stage

  • Delegate coffee breaks and lunch for 2 days
DELEGATE PASS

Standard & Onsite Registration

$799

Prices from 16 April.

$399 for government & Ph.D. research students.

For govt., use code: GOVPMES24
For students, use code: STUPMES24

Includes access to:
  • Everything included in the visitor registration plus;

  • Full access to CME accredited Scientific Conference on the PMES Main Stage

  • Delegate coffee breaks and lunch for 2 days

precisionmed Scientific conference

PrecisionMed Exhibition & Summit (PMES) 2024 welcomes speakers from the Middle East and beyond to represent global developments in precision medicine across borders with the purpose of accelerating the adaptation within the region.

The conference will cover four main themes which align with regional government growth strategies in the sector:

  • Healthy populations
  • Lifestyle intervention & disease prevention
  • Clinical genomics
  • AI in precision medicine

Pmes 2024 SPEAKERS

Dr. Ahmad Abou Tayoun

Director, Al Jalila Children’s Genomics Center of Excellence; Associate Professor of Genetics, MBRU

Dr. Khulood Alsayegh, MD

Head of Clinical Standards and Guidelines, Dubai Health Authority

Dr. Khalid Fakhro

Chief Research Officer, Sidra Medicine

Heidi Rehm, Ph.D

Chief Genomics Officer, Center for Genomic Medicine and Department of Medicine at Massachusetts General Hospital

Ibrahim Almaghlouth

Director, Population Health Activation Program, NEOM

Dr. Min S. Park

Chief Scientific Officer, Sanimed International

Jimi Olaghere

CRISPR Gene Editing Recipient

Momchilo Vuyisich

Co-founder, Chief Science Officer, and Head of Clinical Research, Viome Life Sciences

Dr. Reham Kotb

Assistant Prof. of Public Health, Chair of the Environmental and Public Health Department College of Health Sciences,
Abu Dhabi University

Dr. Aliya Al Hosni

Head of the Genetics Laboratories, Oman National Genetics Center

Nader Al-Dewik, Ph.D

Director of Translational and Precision Medicine Research, Principal Investigator, Hamad Medical Corporation (HMC)

Mohamed Nagy

Head of Personalized Medication Management Unit, Children’s Cancer Hospital, Egypt

Prof. Bassam Ali

Professor in Molecular and Genetic Medicine & Leader of the Genetics and Development Research, UAE University

Dr. Wejdan M. Alenezi

Personalized Healthcare,
NEOM

Dr. Alessio Squassina

Associate professor of Pharmacology; Chief – Laboratory of Pharmacogenomics, Dept of Biomedical Sciences, University of Cagliari

Dr. Ali Tinazli

Chief Executive Officer, lifespin GmbH

Dr. Shaikha AlMazrouei

Lead Researcher, Technical Innovation Institute (TII)

Dr. Alka Chaubey, Ph.D, FACMG

Chief Medical Officer, Bionano

Dr. Apostolos Zaravinos

Professor, Cancer Genetics, European University Cyprus

Dr. Ammira Al-Shabeeb Akil, Ph.D

Principal Investigator and the Head of the Precision Medicine of Diabetes Prevention Program; Lead of the Genetic and Metabolic Clinical Research Program, Sidra Medicine

Farah Hillou

Wellbeing Counselor and Nutrition Specialist, G42 Healthcare

Dr. Fawad Khan

Program Lead, Hereditary High Risk and Cancer Survivorship Programs, Oncology Institute, Cleveland Clinic Abu Dhabi

Prof. George P. Patrinos

Professor and Head of Laboratory; Editor-in-Chief, The Pharmacogenomics Journal, University of Patras

Prof. Fatma Al Jasmi

Chair of Genetics & Genomics Department, UAE University College of Medicine & Health Science

Dr. Halima Bensmail

Principal Scientist Qatar Computing Research Institute; Professor, HBKU; Member of the Advisory Board of International AIQT

Dr. Houari B. Abdesselem, Ph.D

Core Manager, Proteomics Core Facility, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar

Dr. Julie Decock

Scientist, Qatar Biomedical Research Institute

Dr. Chiara Cugno

Director of Advanced Cell Therapy Core; Attending Physician,
Sidra Medicine

Mohammed Uddin, Ph.D

Director, Center for Applied and Translational Genomics (CATG), Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health

Dr. M. Walid Qoronfleh, Ph.D., MBA

Executive Director, Q3 Research Institute (QRI)

Dr. Hazim Najjar, MD, ABMGG, FACMG

Executive Board Member, Saudi Society of Medical Genetics

Dr. Maria Vranceanu

Researcher, University of Medicine and Pharmacy Cluj Napoca, Romania

Dr. Maxime Hebrard Ph.D

Senior Scientist, A*STAR – Genome Institute of Singapore

Dr. Ozge Ceyhan Birsoy

Associate Director, Memorial Sloan Kettering Cancer Center, Diagnostic Molecular Genetics Laboratory

Patrick Merel. PhD

Genomics and Molecular Biotech Sr Director, Technical Innovation Institute (TII)

Prof. Dr. Ron H.N. van Schaik

Head, Dept. of Clinical Chemistry / Professor Clinical Chemistry & Pharmacogenetics, Erasmus MC University Medical Center; Director, International (IFCC) Expert Center for Pharmacogenetics

Dr. Sahar Da’as

Research Manager, Sidra Medicine; Adjunct Assistant Professor, Hamad Bin Khalifa University

Dr. Sharmeen Roy, PharmD, BCPS

Chief Strategy & Science Officer, DoseMeRx

Dr. Shruti Sinha, Ph.D

Bioinformatics Scientist, Al Jalila Children’s Specialty Hospital

Dr. Georgios Pavlou

Founder, VNous

Moeen Riaz

Principal Scientist, Regeneron Genetics Center

Dr. Stephen R. Grobmyer, MD

Chair of the Oncology Institute, Cleveland Clinic Abu Dhabi

Radhakrishnan Mahalingam

Healthcare Transformation Leader

Dr. Suruchi Aggarwal, Ph.D

Head Scientific Affairs, MedGenome

Dr. Yosr Hamdi

Biologist and researcher, Institut Pasteur de Tunis, Tunisia

Dr. Boutros Maroun

Senior Manager, Medical Affairs, Illumina

Sujash Chatterjee

Global Market Development Lead, Cancer Research and Multiomics Applications, Illumina

Dr. Hussein A. Abbas, M.D., Ph.D.

Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center

Dr. Mithua Ghosh

Director, HCG Oncology

DISCOVER LATEST SOLUTIONS. LEAVE WITH NEW UNDERSTANDING FOR THE BENEFIT OF MENA’S PATIENT COMMUNITY

  • Increase your understanding of the basis for current effective targeted therapies in disease based on molecular, environmental, and patient lifestyle factors.
  • Identify global and national needs in healthcare to reduce the social burden of malignancy and chronic diseases.
  • Update your understanding of current diagnostic and therapeutic clinical guidelines and best practices in precision medicine in all areas.

Testominials

This is one of the best precision medicine events I have attended!

Mohamed Nagy
Head of Personalized Medication Management Unit, Children’s Cancer Hospital, Egypt

From personalized diagnostics and genomic medicine to AI-driven therapies and advanced imaging, this event is a game-changer for the industry. Great opportunity to explore the exhibition floor, where leading companies and startups are showcasing their latest products and services.

Rémy Levastre
Director of Healthcare Advisory Services at WSP